Miller-Fisher syndrome after SARS-CoV-2 infection.

Reyes-Bueno, J A; García-Trujillo, L; Urbaneja, P; Ciano-Petersen, N L; Postigo-Pozo, M J; Martínez-Tomás, C; Serrano-Castro, P J

Reyes-Bueno, J A; García-Trujillo, L; Urbaneja, P; Ciano-Petersen, N L; Postigo-Pozo, M J; Martínez-Tomás, C; Serrano-Castro, P J.

Afiliação

Reyes-Bueno JA; Neurology Department, Regional University Hospital of Málaga, Málaga, Spain.
García-Trujillo L; Neurology Department, Regional University Hospital of Málaga, Málaga, Spain.
Urbaneja P; Neurology Department, Regional University Hospital of Málaga, Málaga, Spain.
Ciano-Petersen NL; Neurology Department, Regional University Hospital of Málaga, Málaga, Spain.
Postigo-Pozo MJ; Neurophysiology Department, Regional University Hospital of Málaga, Málaga, Spain.
Martínez-Tomás C; Neurology Department, Regional University Hospital of Málaga, Málaga, Spain.
Serrano-Castro PJ; Neurology Department, Regional University Hospital of Málaga, Málaga, Spain.

Eur J Neurol ; 27(9): 1759-1761, 2020 09.

Article em En | MEDLINE | ID: mdl-32503084

Assuntos

COVID-19/complicações; Síndrome de Miller Fisher/etiologia; Feminino; Humanos; Imunoglobulinas Intravenosas; Pessoa de Meia-Idade; Síndrome de Miller Fisher/tratamento farmacológico; Resultado do Tratamento

Palavras-chave

COVID-19; Guillain-Barré syndrome; Miller-Fisher variant; SARS-CoV-2; acute inflammatory demyelinating polyneuropathy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Miller Fisher / COVID-19 Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Miller Fisher / COVID-19 Idioma: En Ano de publicação: 2020 Tipo de documento: Article